These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22271903)

  • 21. Flow cytometry for diagnosis and assessment of prognosis in patients with myelodysplastic syndromes.
    Benesch M; Deeg HJ; Wells D; Loken M
    Hematology; 2004 Jun; 9(3):171-7. PubMed ID: 15204098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of erythroid maturation in the nonlysed bone marrow with help of radar plots facilitates detection of flow cytometric aberrations in myelodysplastic syndromes.
    Violidaki D; Axler O; Jafari K; Bild F; Nilsson L; Mazur J; Ehinger M; Porwit A
    Cytometry B Clin Cytom; 2020 Sep; 98(5):399-411. PubMed ID: 32543774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic and prognostic significance of flow cytometric bone marrow assessment in myelodysplastic syndromes according to the European LeukemiaNet recommendations in single-centre real-life experience.
    Majcherek M; Kiernicka-Parulska J; Mierzwa A; Barańska M; Matuszak M; Lewandowski K; Komarnicki M; Czyż A
    Scand J Immunol; 2021 Aug; 94(2):e13028. PubMed ID: 33577137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research advances in value of flow cytometric immunophenotyping in diagnosis and prognostic evaluation of myelodysplastic syndrome].
    Lu D; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):785-90. PubMed ID: 23815941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of CD34
    Duarte FB; DE Jesus Dos Santos TE; Barbosa MC; Moura ATG; DE Vasconcelos JPL; Rocha-Filho FD; Coutinho DF; Zalcberg I; Vasconcelos PRL; Garcia YDO; Lemes RPG
    In Vivo; 2019; 33(1):277-280. PubMed ID: 30587636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes.
    Verigou E; Lampropoulou P; Smyrni N; Kolliopoulou G; Sakellaropoulos G; Starakis I; Zikos P; Solomou E; Symeonidis A; Karakantza M
    Cardiovasc Hematol Disord Drug Targets; 2015; 15(2):148-61. PubMed ID: 26126819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bernard-Soulier syndrome: quantitative characterization of megakaryocytes and platelets by flow cytometric and platelet kinetic measurements.
    Tomer A; Scharf RE; McMillan R; Ruggeri ZM; Harker LA
    Eur J Haematol; 1994 Apr; 52(4):193-200. PubMed ID: 8005229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group.
    Westers TM; Cremers EM; Oelschlaegel U; Johansson U; Bettelheim P; Matarraz S; Orfao A; Moshaver B; Brodersen LE; Loken MR; Wells DA; Subirá D; Cullen M; Te Marvelde JG; van der Velden VH; Preijers FW; Chu SC; Feuillard J; Guérin E; Psarra K; Porwit A; Saft L; Ireland R; Milne T; Béné MC; Witte BI; Della Porta MG; Kern W; van de Loosdrecht AA;
    Haematologica; 2017 Feb; 102(2):308-319. PubMed ID: 27758818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnostic significance of immunophenotyping of bone marrow cells in myelodysplastic syndrome without an increase of marrow blasts].
    Xu J; Zhang W; Liu Y; Wan SG; Sun XJ; Zhao H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1477-81. PubMed ID: 20030930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Significance of Platelet Recovery in Myelodysplastic Syndromes With Severe Thrombocytopenia.
    Tang Y; Zhang X; Han S; Chu T; Qi J; Wang H; Tang X; Qiu H; Fu C; Ruan C; Wu D; Han Y
    Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):217S-222S. PubMed ID: 30296835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between the expression levels of CD61, CD63, and PAC-1 on platelet surface in peripheral blood and the transplanted kidney function.
    Zhang Y; Guan DL; Xia CQ; Han ZY; Xu JJ; Gao JZ; Wu KR
    Transplant Proc; 2003 Jun; 35(4):1360-3. PubMed ID: 12826159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
    Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of immunophenotype on prognosis of patients with myelodysplastic syndromes. Its value in patients without karyotypic abnormalities.
    Arroyo JL; Fernández ME; Hernández JM; Orfao A; San Miguel JF; del Cañizo MC
    Hematol J; 2004; 5(3):227-33. PubMed ID: 15167909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myelodysplastic syndromes: the role of flow cytometry in diagnosis and prognosis.
    Stetler-Stevenson M; Yuan CM
    Int J Lab Hematol; 2009 Oct; 31(5):479-83. PubMed ID: 19555363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.
    Cremers EMP; Westers TM; Alhan C; Cali C; Wondergem MJ; Poddighe PJ; Ossenkoppele GJ; van de Loosdrecht AA
    Eur J Cancer; 2016 Feb; 54():49-56. PubMed ID: 26720403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes.
    Tang G; Wang SA; Menon M; Dresser K; Woda BA; Hao S
    Leuk Res; 2011 Jun; 35(6):766-70. PubMed ID: 21367453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders.
    Harrington A; Olteanu H; Kroft S
    Am J Clin Pathol; 2010 Nov; 134(5):749-61. PubMed ID: 20959658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemorrhagic risk due to platelet dysfunction in myelodysplastic patients, correlations with anemia severity and iron overload.
    Popov VM; Vladareanu AM; Bumbea H; Kovacs E; Savopol T; Iordache MM; Moisescu MG
    Blood Coagul Fibrinolysis; 2015 Oct; 26(7):743-9. PubMed ID: 25811447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometry demonstrates differences in platelet reactivity and microparticle formation in subjects with thrombocytopenia or thrombocytosis due to primary haematological disorders.
    Connor DE; Ma DD; Joseph JE
    Thromb Res; 2013 Nov; 132(5):572-7. PubMed ID: 24094604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia.
    Oliveira AF; Tansini A; Vidal DO; Lopes LF; Metze K; Lorand-Metze I
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27748021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.